Advanced or Metastatic Biliary Tract Cancer
4 clinical trials · Condition
◉ Watch Advanced or Metastatic Biliary Tract Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer (NCT04837508) | Shanghai Miracogen Inc. | 2021-06-07 |
| A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer (NCT04838964) | Shanghai Miracogen Inc. | 2021-04-28 |
| Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer (NCT03129074) | ASLAN Pharmaceuticals | 2018-05-01 |
| A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours (NCT03082053) | ASLAN Pharmaceuticals | 2017-01-31 |
Track Advanced or Metastatic Biliary Tract Cancer automatically
Every clearance here is in the API, with alerts when new ones post.